AT&T Inc. raises to outperform rating; raises target price to $30 from $26
T•Related News
Churchill Downs schedules Q3 earnings release and conference call
CHDN•
Quest Diagnostics study finds 29.5% of Lyme-seropositive patients show antibodies to other tick-borne pathogens
DGX•
Corteva Vylor Partners With Rainbow Crops On Gene-Edited Corn Development Using AI And Multiplex Gene Editing
CTVA•
Ameresco picked for exclusive talks on U.S. Army power projects at Aberdeen, Picatinny sites
AMRC•
Ocean Capital Acquisition sponsor SB Capital ownership shifts to Chi-Ping Cindy Lee at 100%
OCAC•